A detailed history of First Bank & Trust transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First Bank & Trust holds 12,091 shares of EW stock, worth $904,527. This represents 0.16% of its overall portfolio holdings.

Number of Shares
12,091
Previous 21,936 44.88%
Holding current value
$904,527
Previous $2.03 Million 60.66%
% of portfolio
0.16%
Previous 0.43%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$59.7 - $93.78 $587,746 - $923,264
-9,845 Reduced 44.88%
12,091 $797,000
Q2 2024

Jul 09, 2024

BUY
$84.3 - $94.31 $80,590 - $90,160
956 Added 4.56%
21,936 $2.03 Million
Q1 2024

Apr 17, 2024

BUY
$72.54 - $95.56 $35,544 - $46,824
490 Added 2.39%
20,980 $2 Million
Q4 2023

Jan 12, 2024

SELL
$61.71 - $77.76 $191,794 - $241,678
-3,108 Reduced 13.17%
20,490 $1.56 Million
Q3 2023

Oct 11, 2023

SELL
$69.28 - $93.38 $3,810 - $5,135
-55 Reduced 0.23%
23,598 $1.63 Million
Q2 2023

Jul 12, 2023

BUY
$81.41 - $94.33 $104,856 - $121,497
1,288 Added 5.76%
23,653 $2.23 Million
Q1 2023

Apr 25, 2023

BUY
$74.26 - $84.51 $278,475 - $316,912
3,750 Added 20.15%
22,365 $1.85 Million
Q4 2022

Jan 27, 2023

SELL
$68.3 - $87.44 $237,752 - $304,378
-3,481 Reduced 15.75%
18,615 $1.39 Million
Q3 2022

Oct 28, 2022

BUY
$82.37 - $107.29 $181,214 - $236,038
2,200 Added 11.06%
22,096 $1.83 Million
Q2 2022

Jul 22, 2022

BUY
$86.5 - $128.27 $321,001 - $476,009
3,711 Added 22.93%
19,896 $1.89 Million
Q1 2022

Apr 29, 2022

BUY
$101.96 - $128.34 $185,567 - $233,578
1,820 Added 12.67%
16,185 $1.91 Million
Q4 2021

Feb 01, 2022

BUY
$106.37 - $130.68 $29,783 - $36,590
280 Added 1.99%
14,365 $1.86 Million
Q3 2021

Oct 18, 2021

BUY
$102.91 - $122.75 $2,469 - $2,946
24 Added 0.17%
14,085 $1.59 Million
Q2 2021

Aug 10, 2021

SELL
$83.84 - $104.76 $21,714 - $27,132
-259 Reduced 1.81%
14,061 $1.46 Million
Q1 2021

Apr 14, 2021

BUY
$78.68 - $90.67 $334,468 - $385,438
4,251 Added 42.22%
14,320 $1.2 Million
Q4 2020

Jan 27, 2021

SELL
$71.69 - $91.23 $373,146 - $474,852
-5,205 Reduced 34.08%
10,069 $919,000
Q3 2020

Oct 26, 2020

SELL
$67.19 - $87.44 $422,826 - $550,259
-6,293 Reduced 29.18%
15,274 $1.22 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $983,301 - $1.31 Million
17,089 Added 381.62%
21,567 $1.49 Million
Q1 2020

Apr 14, 2020

BUY
$52.41 - $81.0 $14,569 - $22,518
278 Added 6.62%
4,478 $845,000
Q4 2019

Jan 31, 2020

SELL
$71.7 - $82.09 $28,680 - $32,836
-400 Reduced 8.7%
4,200 $980,000
Q3 2019

Oct 17, 2019

BUY
$61.55 - $75.43 $9,355 - $11,465
152 Added 3.42%
4,600 $1.01 Million
Q2 2019

Jul 26, 2019

BUY
$55.74 - $64.41 $3,790 - $4,379
68 Added 1.55%
4,448 $822,000
Q1 2019

Apr 15, 2019

SELL
$47.89 - $64.05 $34,959 - $46,756
-730 Reduced 14.29%
4,380 $838,000
Q4 2018

Jan 28, 2019

BUY
$46.41 - $56.94 $7,332 - $8,996
158 Added 3.19%
5,110 $783,000
Q2 2018

Jul 31, 2018

BUY
$42.45 - $51.3 $23,474 - $28,368
553 Added 12.57%
4,952 $721,000
Q1 2018

Apr 20, 2018

SELL
$37.19 - $47.45 $371 - $474
-10 Reduced 0.23%
4,399 $614,000
Q4 2017

Jan 18, 2018

SELL
$33.79 - $39.39 $2,601 - $3,033
-77 Reduced 1.72%
4,409 $497,000
Q3 2017

Oct 25, 2017

BUY
$36.29 - $38.83 $162,796 - $174,191
4,486
4,486 $490,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First Bank & Trust Portfolio

Follow First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.